Literature DB >> 17626256

Venous thromboembolism risk among hospitalized patients: magnitude of the risk is staggering.

Samuel Z Goldhaber.   

Abstract

Quality assessment focuses on areas where measurement is easy and unequivocal. To determine whether high quality hospital medicine is being practiced, a natural target is assessment of the frequency of orders to implement preventive strategies against venous thromboembolism. Patient risk can be readily ascertained, and rigorous clinical trials have vetted effective strategies to prevent deep vein thrombosis and pulmonary embolism. Concentrating on reducing the risk of venous thromboembolism is worthwhile because more than 4 million surgical patients and almost 8 million medical patients warrant specific prophylaxis orders each year in the United States alone. For those who do not receive preventive measures, the result may not be apparent during the index hospitalization. More likely, such patients will tend to develop deep vein thrombosis or pulmonary embolism within the ensuing 90 days, either in a skilled nursing facility or at home in the community. It is now time for us to broaden our approach. What happens in the hospital (such as lapses in good hospital practice) does not necessarily stay in the hospital. Failure to prophylax against venous thromboembolism may have potentially devastating implications for months after hospital discharge. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626256     DOI: 10.1002/ajh.20997

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  A systematic review of Cochrane anticoagulation reviews.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2009-01-06

2.  A validated risk model to predict 90-day VTE events in postsurgical patients.

Authors:  Christopher J Pannucci; Sandra Laird; Justin B Dimick; Darrell A Campbell; Peter K Henke
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

Review 3.  Diet as prophylaxis and treatment for venous thromboembolism?

Authors:  David K Cundiff; Paul S Agutter; P Colm Malone; John C Pezzullo
Journal:  Theor Biol Med Model       Date:  2010-08-11       Impact factor: 2.432

4.  Thromboprophylaxis use in medical and surgical inpatients and the impact of an electronic risk assessment tool as part of a multi-factorial intervention. A report on behalf of the elVis study investigators.

Authors:  Edward Janus; Anmol Bassi; David Jackson; Harshal Nandurkar; Mark Yates
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

5.  Venous thromboembolism risk assessment in hospitalised patients: a new proposal.

Authors:  Carolina Alves Vono Alckmin; Mariana Dionísia Garcia; Solange Aparecida Petilo de Carvalho Bricola; Milton de Arruda Martins; Arnaldo Lichtenstein; Edison Ferreira de Paiva
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.